Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686127 · ClinicalTrials.gov registry record · Phase 4
Symptom Management After Breast Cancer Surgery
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT00686127 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 21 participants.
The verdict
NCT00686127, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.
Interventions
- DRUG Placebo patch
- DRUG Lidoderm patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00686127
The ClinicalTrials.gov registry entry for NCT00686127 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo patch is the first listed.
NCT00686127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00686127 about?
NCT00686127 is a clinical study titled "Symptom Management After Breast Cancer Surgery". This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they wi...
What is the current status of trial NCT00686127?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2003-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00686127?
The interventions under investigation include: Placebo patch (DRUG), Lidoderm patch (DRUG).
Who is sponsoring clinical trial NCT00686127?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.